IDO1 and ovarian carcinoma: More recently, it was shown that IDO inhibitors potentiated the antitumour activity of chemotherapeutic agents in mice, suggesting the involvement of IDO in the refractoriness to chemotherapy (Muller et al, 2005), consistent with another report showing that IDO was associated with chemoresistance in ovarian cancer (Okamoto et al, 2005).